Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 691,000 | $84 | — | — |
| Q3 2025 | 428,000 | $43 | — | — |
| Q2 2025 | 428,000 | $35 | — | — |
| Q1 2025 | 254,000 | $21 | — | — |
| Q4 2024 | 534,000 | $48 | — | — |
| Q3 2024 | 1,430,000 | $141 | — | — |
| Q3 2023 | 357,015 | $26 | — | — |
| Q2 2023 | 357,015 | $30 | — | — |
| Q1 2023 | 667,015 | $51 | — | — |
| Q4 2022 | 1,580,000 | $131 | — | — |
| Q3 2022 | 1,580,000 | $125,326 | — | — |
| Q2 2022 | 2,442,000 | $181,367 | — | — |
| Q1 2022 | 2,030,000 | $182,456 | — | — |
| Q4 2021 | 848,000 | $94,942 | — | — |
| Q3 2021 | 571,350 | $71,824 | — | — |
| Q2 2021 | 460,350 | $62,331 | — | — |
| Q1 2021 | 190,350 | $25,821 | — | — |
| Q4 2020 | 523,850 | $68,904 | — | — |
| Q3 2020 | 670,000 | $74,658 | — | — |
| Q2 2020 | 670,000 | $75,006 | — | — |
| Q1 2020 | 935,000 | $72,406 | — | — |
| Q4 2019 | 60,320 | $634,214 | — | — |
| Q3 2019 | 934,214 | $71,234 | — | — |
| Q2 2019 | 934,214 | $81,940 | — | — |
| Q1 2019 | 933,000 | $84,474 | — | — |
| Q4 2018 | 600,000 | $43,050 | — | — |
| Q3 2018 | 600,000 | $57,522 | — | — |
| Q2 2018 | 600,000 | $57,114 | — | — |
| Q1 2018 | 1,352,197 | $118,628 | — | — |
| Q4 2016 | 125,500 | $7,428 | — | — |
| Q3 2016 | 125,500 | $8,319 | — | — |